PL396418A1 - Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA - Google Patents

Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA

Info

Publication number: PL396418A1
Authority: PL; Poland
Prior art keywords: rna; bacitracin; application; hydrolytic degradation; degradation
Prior art date: 2011-09-23

Application number

PL396418A

Other languages

English (en)

Other versions

PL227562B1 (pl

Inventor

Jerzy Ciesiołka

Małgorzata Jeżowska-Bojczuk

Jan Wrzesiński

Justyna Nagaj

Kamila Stokowa-Sołtys

Aleksandra Kasprowicz

Leszek Błaszczyk

Wojciech Szczepanik

Original Assignee

Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-09-23

Filing date

2011-09-23

Publication date

2012-02-27

2011-09-23 Application filed by Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością filed Critical Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością

2011-09-23 Priority to PL396418A priority Critical patent/PL227562B1/pl

2012-02-27 Publication of PL396418A1 publication Critical patent/PL396418A1/pl

2012-09-23 Priority to PCT/IB2012/055059 priority patent/WO2013042093A1/en

2017-12-29 Publication of PL227562B1 publication Critical patent/PL227562B1/pl

Links

108010001478 Bacitracin Proteins 0.000 title abstract 3
229960003071 bacitracin Drugs 0.000 title abstract 3
229930184125 bacitracin Natural products 0.000 title abstract 3
CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 title abstract 3
230000015556 catabolic process Effects 0.000 title abstract 3
238000006731 degradation reaction Methods 0.000 title abstract 3
230000003301 hydrolyzing effect Effects 0.000 title abstract 2
230000003115 biocidal effect Effects 0.000 title 1
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
229910001428 transition metal ion Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL396418A 2011-09-23 2011-09-23 Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA PL227562B1 (pl)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
PL396418A PL227562B1 (pl)	2011-09-23	2011-09-23	Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA
PCT/IB2012/055059 WO2013042093A1 (en)	2011-09-23	2012-09-23	The use of the antibiotic bacitracin in the hydrolytic degradation of rna

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL396418A PL227562B1 (pl)	2011-09-23	2011-09-23	Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA

Publications (2)

Publication Number	Publication Date
PL396418A1 true PL396418A1 (pl)	2012-02-27
PL227562B1 PL227562B1 (pl)	2017-12-29

Family

ID=45699361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL396418A PL227562B1 (pl)	2011-09-23	2011-09-23	Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA

Country Status (2)

Country	Link
PL (1)	PL227562B1 (pl)
WO (1)	WO2013042093A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN111420024B (zh) *	2020-04-07	2023-10-03	中国科学院深圳先进技术研究院	杆菌酞a在制备预防和治疗冠状病毒的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5066783A (en)	1986-05-20	1991-11-19	Cohen Eric A	Antiviral peptides and means for treating herpes infections
US4795740A (en)	1986-05-20	1989-01-03	Cohen Eric A	Antiviral peptides and means for treating herpes infections
WO1994004185A2 (en)	1992-08-19	1994-03-03	Trustees Of Boston University	Method of inhibiting reduction of disulfide bonds

2011
- 2011-09-23 PL PL396418A patent/PL227562B1/pl unknown
2012
- 2012-09-23 WO PCT/IB2012/055059 patent/WO2013042093A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2013042093A1 (en)	2013-03-28
PL227562B1 (pl)	2017-12-29
WO2013042093A8 (en)	2013-10-17

Similar Documents

Publication	Publication Date	Title
EP3033325A4 (en)	2017-07-12	Compositions and methods for delivering messenger rna
EP3087184A4 (en)	2017-08-16	Methods and compositions for the specific inhibition of glycolate oxidase (hao1) by double-stranded rna
IL231825A0 (en)	2014-05-28	Formulations of ethenecept stabilized with metal ions
EP2855680B8 (en)	2020-04-15	Compositions and methods for silencing gene expression
EP3245220A4 (en)	2018-06-13	Methods and compositions for targeted gene transfer
SG10201605172RA (en)	2016-08-30	Compositions and methods for selectively etching titanium nitride
EP3004287A4 (en)	2017-06-21	Compositions and methods for selectively etching titanium nitride
EP3039098A4 (en)	2017-04-19	Compositions and methods for selectively etching titanium nitride
EP2619365A4 (en)	2015-09-16	COMPOSITIONS AND DELIVERY SYSTEMS WITH LEACHABLE METALLIC IONS
EP2661331A4 (en)	2017-07-05	Scrap metal sorting system
IN2014CN04765A (pl)	2015-09-18
ZA201504328B (en)	2016-04-28	Low alloy high toughness wear-resistant steel plate and manufacturing method thereof
WO2012149472A9 (en)	2013-01-03	Methods, compositions, and kits for treating and preventing neurological conditions
WO2011056650A9 (en)	2011-09-01	Methods and compositions for treating and preventing viral infections
SG10201505834VA (en)	2015-09-29	Parasitic plasma prevention in plasma processing chambers
EP3057514A4 (en)	2017-08-02	Formulations and methods for increasing or reducing mucus
WO2012116010A3 (en)	2012-10-26	Antibiotic tolerance inhibitors
EP3257045A4 (en)	2018-08-15	Clock switching in always-on component
IL227682A0 (en)	2013-09-30	Compounds suppressing 17-il and γ- ifn, preparations containing them and their uses
ZA201109492B (en)	2013-03-27	Compositions comprising finafloxacin and methods for treating ophthalmic,otic,or nasal infections
EP3303589A4 (en)	2019-01-02	Mir-155 inhibitors for treating amyotrophic lateral sclerosis (als)
WO2013023059A3 (en)	2013-04-04	Methods and compositions for the treatment of autoimmune and inflammatory diseases
EP2663671A2 (en)	2013-11-20	Metal treatment
EP2762554A4 (en)	2015-03-25	GREASE COMPOSITION FOR A BEARING BEARING AND BEARING BEARING
MY156185A (en)	2016-01-19	Gene controlling fruit color phenotype in palm